Skip to main content

Advertisement

Log in

Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

An Erratum to this article was published on 05 February 2010

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Cummings SR, Martin JS, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756–765

    Article  CAS  PubMed  Google Scholar 

  2. Anastasilakis AD, Toulis KA, Goulis DG et al (2009) Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res 41(10):721–729

    Article  CAS  PubMed  Google Scholar 

  3. Ellis GK, Bone HG, Chlebowski R et al (2008) Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol 20, 26(30):4875–4882

    Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. A. Toulis.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00198-010-1173-x

Rights and permissions

Reprints and permissions

About this article

Cite this article

A. Toulis, K., D. Anastasilakis, A. Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab. Osteoporos Int 21, 1963–1964 (2010). https://doi.org/10.1007/s00198-009-1145-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-1145-1

Keywords

Navigation